- Home
- AKRO vs ALRM Comparison
AKRO vs ALRM Comparison
Compare AKRO & ALRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- ALRM
- Stock Information
- Founded
- AKRO 2017
- ALRM 2000
- Country
- AKRO United States
- ALRM United States
- Employees
- AKRO N/A
- ALRM N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- ALRM Computer Software: Prepackaged Software
- Sector
- AKRO Health Care
- ALRM Technology
- Exchange
- AKRO Nasdaq
- ALRM Nasdaq
- Market Cap
- AKRO 3.5B
- ALRM 2.9B
- IPO Year
- AKRO 2019
- ALRM 2015
- Fundamental
- Price
- AKRO $40.48
- ALRM $55.65
- Analyst Decision
- AKRO Strong Buy
- ALRM Buy
- Analyst Count
- AKRO 9
- ALRM 5
- Target Price
- AKRO $76.29
- ALRM $64.40
- AVG Volume (30 Days)
- AKRO 938.9K
- ALRM 376.3K
- Earning Date
- AKRO 05-09-2025
- ALRM 05-08-2025
- Dividend Yield
- AKRO N/A
- ALRM N/A
- EPS Growth
- AKRO N/A
- ALRM 49.84
- EPS
- AKRO N/A
- ALRM 2.29
- Revenue
- AKRO N/A
- ALRM $939,827,000.00
- Revenue This Year
- AKRO N/A
- ALRM $6.31
- Revenue Next Year
- AKRO N/A
- ALRM $4.29
- P/E Ratio
- AKRO N/A
- ALRM $24.10
- Revenue Growth
- AKRO N/A
- ALRM 6.59
- 52 Week Low
- AKRO $17.86
- ALRM $51.87
- 52 Week High
- AKRO $58.40
- ALRM $72.37
- Technical
- Relative Strength Index (RSI)
- AKRO 36.69
- ALRM 33.84
- Support Level
- AKRO $41.84
- ALRM $56.04
- Resistance Level
- AKRO $45.38
- ALRM $58.42
- Average True Range (ATR)
- AKRO 1.98
- ALRM 1.15
- MACD
- AKRO -0.40
- ALRM -0.12
- Stochastic Oscillator
- AKRO 16.39
- ALRM 22.11
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About ALRM Alarm.com Holdings Inc.
Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices.